Gaul; Micheal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gaul; Micheal.The latest application filed is for "indazole derivatives useful as glucagon receptor antagonists".

Company Profile

9.18.14

Gaul; Micheal - Yardley PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indazole derivatives useful as glucagon receptor antagonists Grant 11,098,016 - Xu , et al. August 24, 2	2021-08-24
5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators Grant 11,014,917 - Xu , et al. May 25, 2	2021-05-25
Indazole Derivatives Useful As Glucagon Receptor Antagonists App 20200377462 - Xu; Guozhang ; et al.	2020-12-03
Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators Grant 10,815,210 - Gaul , et al. October 27, 2	2020-10-27
5-fluoro-c-(aryl Or Heterocyclyl)-glycoside Derivatives Useful As Dual Sglt1 / Sglt2 Modulators App 20200291004 - Xu; Guozhang ; et al.	2020-09-17
Indazole derivatives useful as glucagon receptor antagonists Grant 10,774,048 - Xu , et al. Sept	2020-09-15
5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators Grant 10,696,662 - Xu , et al. June 30, 2	2020-06-30
Benzocyclobutane Derivatives Useful As Dual Sglt1 / Sglt2 Modulators App 20190367469 - Gaul; Micheal ; et al.	2019-12-05
Indazole Derivatives Useful As Glucagon Receptor Antagonists App 20190218186 - Xu; Guozhang ; et al.	2019-07-18
Indole derivatives useful as glucagon receptor antagonists Grant 10,251,864 - Gaul , et al.	2019-04-09
Indazole derivatives useful as glucagon receptor antagonists Grant 10,214,493 - Gaul , et al. Feb	2019-02-26
5-fluoro-c-(aryl Or Heterocyclyl)-glycoside Derivatives Useful As Dual Sglt1 / Sglt2 Modulators App 20190055226 - Xu; Guozhang ; et al.	2019-02-21
Indazole derivatives useful as glucagon receptor antagonists Grant 10,000,473 - Gaul , et al. June 19, 2	2018-06-19
Indazole Derivatives Useful As Glucagon Receptor Antagonists App 20180065934 - Gaul; Micheal ; et al.	2018-03-08
Indazole Derivatives Useful As Glucagon Receptor Antagonists App 20180065955 - Gaul; Micheal ; et al.	2018-03-08
Indole Derivatives Useful As Glucagon Receptor Antagonists App 20180064686 - Gaul; Micheal ; et al.	2018-03-08
Dual SGLT1/SGLT2 inhibitors Grant 9,012,412 - Gaul , et al. April 21, 2	2015-04-21
Dual Sglt1/sglt2 Inhibitors App 20140256657 - Gaul; Micheal ; et al.	2014-09-11
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-.alpha. modulators Grant 8,796,256 - Bignan , et al. August 5, 2	2014-08-05
Aminothiazolones as estrogen related receptor-alpha modulators Grant 8,445,690 - Bignan , et al. May 21, 2	2013-05-21
Aminothiazolones as estrogen related receptor-alpha modulators Grant 8,426,604 - Bignan , et al. April 23, 2	2013-04-23
Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators Grant 8,399,681 - Bignan , et al. March 19, 2	2013-03-19
Substituted Aminothiazolone Indazoles As Estrogen Related Receptor-alpha Modulators App 20120302544 - Bignan; Gilles ; et al.	2012-11-29
Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators Grant 8,263,781 - Bignan , et al. September 11, 2	2012-09-11
SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS App 20110294780 - Bignan; Gilles ; et al.	2011-12-01
Aminothiazolones As Estrogen Related Receptor-alpha Modulators App 20110200586 - BIGNAN; Gilles ; et al.	2011-08-18
Aminothiazolones As Estrogen Related Receptor-alpha Modulators App 20110200587 - Bignan; Gilles ; et al.	2011-08-18
Substituted Aminothiazolone Indazoles As Estrogen Related Receptor-alpha Modulators App 20110150864 - BIGNAN; Gilles ; et al.	2011-06-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.